Shintaro Nakagawa

Osteonecrosis development in a novel rat model characterized by a single application of oxidative stress

Toru Ichiseki, Ayumi Kaneuji, Yoshimichi Ueda et al. · Arthritis & Rheumatism · 2011 · 50 citations

Medicine, Pharmacology, Bone Metabolism +14

Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

Hiroji Iwata, Kenichi Inoue, Koji Kaneko et al. · Japanese Journal of Clinical Oncology · 2019 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

Toshihiko Doi, Yutaka Fujiwara, Nobuaki Matsubara et al. · Cancer Chemotherapy and Pharmacology · 2019 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer

Junichiro Watanabe, Yoshinori Ito, Toshiaki Saeki et al. · In Vivo · 2017 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer

Kazuma Kishi, Hiroshi Sakai, Takashi Seto et al. · Cancer Treatment and Research Communications · 2018 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17